Evidence map›Paper›PMID 37268964›Full record

ArticleOrphanet journal of rare diseases2023

A qualitative study on the perspectives of mothers who had been diagnosed with primary carnitine deficiency through newborn screening of their child.

Lieke M van den Heuvel, Adriana Kater-Kuipers, Tessa van Dijk, Loek L Crefcoeur, Gepke Visser, Mirjam Langeveld, Lidewij Henneman

Open access · goldAbstract read
In one paragraph

Article in Orphanet journal of rare diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Lieke M van den HeuvelDepartment of Human Genetics, Amsterdam UMC, location Vrije Universiteit, Amsterdam, the Netherlands.
Adriana Kater-KuipersDepartment of Human Genetics, Amsterdam UMC, location Vrije Universiteit, Amsterdam, the Netherlands.
Tessa van DijkDepartment of Human Genetics, Amsterdam UMC, location Vrije Universiteit, Amsterdam, the Netherlands.
Loek L CrefcoeurWilhelmina Children's Hospital, Section Metabolic Diseases, University Medical Centre Utrecht, Utrecht, the Netherlands.
Gepke VisserWilhelmina Children's Hospital, Section Metabolic Diseases, University Medical Centre Utrecht, Utrecht, the Netherlands.
Mirjam LangeveldDepartment of Endocrinology and Metabolism, Amsterdam UMC, location University of Amsterdam, Amsterdam, the Netherlands.
Lidewij HennemanDepartment of Human Genetics, Amsterdam UMC, location Vrije Universiteit, Amsterdam, the Netherlands. l.henneman@amsterdamumc.nl.ORCID 0000-0003-3531-0597
Amsterdam University Medical Centers · NLWilhelmina Children's Hospital · NLGGD Amsterdam · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPrimary carnitine deficiency is an inborn error of metabolism, which can lead to life-threating complications early in life. Low carnitine levels can be detected by newborn bloodspot screening (NBS). However, NBS can also identify, mostly asymptomatic, mothers with primary carnitine deficiency. To identify mothers' needs and areas for improving screening practice, this study explored the experiences with, and opinions on primary carnitine deficiency screening in NBS among women diagnosed through NBS of their newborn.

methodsTwelve Dutch women were interviewed, 3-11 years after diagnosis. Data were analysed using a thematic approach.

resultsFour main themes were derived: 1) psychological impact of primary carnitine deficiency diagnosis, 2) becoming a patient and "patient-in-waiting", 3) information issues and care provision, and 4) primary carnitine deficiency as part of the NBS panel. Mothers shared that they did not experience major psychological distress of the diagnosis. They did experience (recall) various emotions following the initial abnormal NBS result, including fear and anxiety as well as relief, and emotions regarding their own diagnosis, including uncertainty about health risks and treatment effectiveness. Some felt a patient-in-waiting. Many participants experienced a lack of information, especially shortly after receiving the abnormal NBS result. All shared the belief that screening for primary carnitine deficiency in NBS is beneficial for the newborn, and, given the information they received, also considered the knowledge beneficial for their own health.

conclusionsPsychological burden following diagnosis was experienced by women as limited, although the experienced lack of information amplified feelings of uncertainty and anxiety. Most mothers believed that benefits of knowing about primary carnitine deficiency outweighed the disadvantages. Mothers' perspectives should be incorporated in policy-making about primary carnitine deficiency in NBS.

Indexed as

CardiomyopathiesMuscular DiseasesCarnitineFemaleHumansHyperammonemiaInfant, NewbornMothersNeonatal ScreeningCarnitineEmotionsExperienceInterviewsMaternal primary carnitine deficiencyMothersNewborn screeningOCTN2 deficiencyOpinionPsychological impact

Identifiers

PMID37268964
PMCPMC10236393
OpenAlexW4379197471

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.